| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Dale R Pfost last filed a Form 4 in March 2022, as Chief Executive Officer at CMMB. Dale R Pfost's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,500 shares of CMMB. Net of sales, the CMMB filings show accumulation of 2,500 shares.
Dale R Pfost has 1 Form 4 filing on record in March 2022, as Chief Executive Officer at Chemomab Therapeutics (CMMB), 2022.
The 3 reported transactions were 2 open-market purchases and 1 option or other derivative award.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 2,500 shares of CMMB at an average $3.98 on March 14, 2022, about $10K. Twelve months later CMMB was down 62%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | CMMB Chemomab Therapeutics Ltd. | Chief Executive Officer | Buy | 2,500 | $3.98 | $9,943.00 | New | -15.4% | -62.5% |